277 related articles for article (PubMed ID: 31961896)
1. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
Hua Y; Ou X; Li Q; Zhu T
PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
[TBL] [Abstract][Full Text] [Related]
3. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
Shao S; Kang H; Tong Z
BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
[TBL] [Abstract][Full Text] [Related]
4. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.
Tao W; Yang LQ; Gao J; Shao J
J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621
[TBL] [Abstract][Full Text] [Related]
6. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Lyu T; Lee YS; Dhanvijay S; Freebairn R
Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
[TBL] [Abstract][Full Text] [Related]
7. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
8. The role of neuromuscular blockers in ARDS: benefits and risks.
Hraiech S; Forel JM; Papazian L
Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blockers in early acute respiratory distress syndrome.
Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
[TBL] [Abstract][Full Text] [Related]
10. [A meta-analysis of the effect of neuromuscular blocking agents on oxygenation in patients with acute respiratory distress syndrome].
Gao ZW; Li C; Chen H; Xie JF; Liu L; Yang Y
Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):86-94. PubMed ID: 34979776
[No Abstract] [Full Text] [Related]
11. Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis.
Guo L; Xie J; Huang Y; Pan C; Yang Y; Qiu H; Liu L
BMC Anesthesiol; 2018 Nov; 18(1):172. PubMed ID: 30447683
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
Torbic H; Krishnan S; Harnegie MP; Duggal A
Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Ho ATN; Patolia S; Guervilly C
J Intensive Care; 2020; 8():12. PubMed ID: 32015880
[TBL] [Abstract][Full Text] [Related]
14. [The effect of neuromuscular blocking agents on prognosis of patients with acute respiratory distress syndrome: a meta analysis].
Wang AT; Gao JL; Li XL; Leng YX; Yao ZY; Zhu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):149-53. PubMed ID: 23656767
[TBL] [Abstract][Full Text] [Related]
15. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
Mefford B; Donaldson JC; Bissell BD
Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
[No Abstract] [Full Text] [Related]
16. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
[TBL] [Abstract][Full Text] [Related]
17. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.
Meng SS; Chang W; Lu ZH; Xie JF; Qiu HB; Yang Y; Guo FM
BMC Pulm Med; 2019 Jan; 19(1):9. PubMed ID: 30626363
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.
Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W;
Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344
[TBL] [Abstract][Full Text] [Related]
19. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP)
Zheng X; Jiang Y; Jia H; Ma W; Han Y; Li W
Ther Adv Respir Dis; 2019; 13():1753466619858228. PubMed ID: 31269867
[TBL] [Abstract][Full Text] [Related]
20. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
